These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 1320272)
1. Molecular dosimetry of aflatoxin DNA adducts in humans and experimental rat models. Groopman JD; Roebuck BD; Kensler TW Prog Clin Biol Res; 1992; 374():139-55. PubMed ID: 1320272 [TBL] [Abstract][Full Text] [Related]
2. Do aflatoxin-DNA adduct measurements in humans provide accurate data for cancer risk assessment? Groopman JD IARC Sci Publ; 1988; (89):55-62. PubMed ID: 3143672 [TBL] [Abstract][Full Text] [Related]
3. The use of monoclonal antibody affinity columns for assessing DNA damage and repair following exposure to aflatoxin B1. Groopman JD; Kensler TW Pharmacol Ther; 1987; 34(2):321-34. PubMed ID: 3120202 [TBL] [Abstract][Full Text] [Related]
4. Molecular dosimetry of urinary aflatoxin-DNA adducts in people living in Guangxi Autonomous Region, People's Republic of China. Groopman JD; Zhu JQ; Donahue PR; Pikul A; Zhang LS; Chen JS; Wogan GN Cancer Res; 1992 Jan; 52(1):45-52. PubMed ID: 1727385 [TBL] [Abstract][Full Text] [Related]
5. Molecular dosimetry of aflatoxin-N7-guanine in human urine obtained in The Gambia, West Africa. Groopman JD; Hall AJ; Whittle H; Hudson GJ; Wogan GN; Montesano R; Wild CP Cancer Epidemiol Biomarkers Prev; 1992; 1(3):221-7. PubMed ID: 1339082 [TBL] [Abstract][Full Text] [Related]
6. Molecular dosimetry in rat urine of aflatoxin-N7-guanine and other aflatoxin metabolites by multiple monoclonal antibody affinity chromatography and immunoaffinity/high performance liquid chromatography. Groopman JD; Hasler JA; Trudel LJ; Pikul A; Donahue PR; Wogan GN Cancer Res; 1992 Jan; 52(2):267-74. PubMed ID: 1728400 [TBL] [Abstract][Full Text] [Related]
7. Temporal patterns of aflatoxin-albumin adducts in hepatitis B surface antigen-positive and antigen-negative residents of Daxin, Qidong County, People's Republic of China. Wang JS; Qian GS; Zarba A; He X; Zhu YR; Zhang BC; Jacobson L; Gange SJ; Muñoz A; Kensler TW Cancer Epidemiol Biomarkers Prev; 1996 Apr; 5(4):253-61. PubMed ID: 8722216 [TBL] [Abstract][Full Text] [Related]
8. Molecular dosimetry of urinary aflatoxin-N7-guanine and serum aflatoxin-albumin adducts predicts chemoprotection by 1,2-dithiole-3-thione in rats. Groopman JD; DeMatos P; Egner PA; Love-Hunt A; Kensler TW Carcinogenesis; 1992 Jan; 13(1):101-6. PubMed ID: 1733561 [TBL] [Abstract][Full Text] [Related]
9. Molecular biomarkers for aflatoxins: from adducts to gene mutations to human liver cancer. Groopman JD; Wang JS; Scholl P Can J Physiol Pharmacol; 1996 Feb; 74(2):203-9. PubMed ID: 8723033 [TBL] [Abstract][Full Text] [Related]
10. Mechanism of protection against aflatoxin tumorigenicity in rats fed 5-(2-pyrazinyl)-4-methyl-1,2-dithiol-3-thione (oltipraz) and related 1,2-dithiol-3-thiones and 1,2-dithiol-3-ones. Kensler TW; Egner PA; Dolan PM; Groopman JD; Roebuck BD Cancer Res; 1987 Aug; 47(16):4271-7. PubMed ID: 2886217 [TBL] [Abstract][Full Text] [Related]
11. Molecular epidemiology of aflatoxin exposures: validation of aflatoxin-N7-guanine levels in urine as a biomarker in experimental rat models and humans. Groopman JD; Wild CP; Hasler J; Junshi C; Wogan GN; Kensler TW Environ Health Perspect; 1993 Mar; 99():107-13. PubMed ID: 8319607 [TBL] [Abstract][Full Text] [Related]
12. Aflatoxins as risk factors for hepatocellular carcinoma in humans. Wogan GN Cancer Res; 1992 Apr; 52(7 Suppl):2114s-2118s. PubMed ID: 1311989 [TBL] [Abstract][Full Text] [Related]
13. Susceptibility to aflatoxin B1-related primary hepatocellular carcinoma in mice and humans. McGlynn KA; Hunter K; LeVoyer T; Roush J; Wise P; Michielli RA; Shen FM; Evans AA; London WT; Buetow KH Cancer Res; 2003 Aug; 63(15):4594-601. PubMed ID: 12907637 [TBL] [Abstract][Full Text] [Related]
15. Effects of multiple risk factors for hepatocellular carcinoma on formation of aflatoxin B1-DNA adducts. Yu MW; Lien JP; Liaw YF; Chen CJ Cancer Epidemiol Biomarkers Prev; 1996 Aug; 5(8):613-9. PubMed ID: 8824363 [TBL] [Abstract][Full Text] [Related]
16. Modulation of aflatoxin metabolism, aflatoxin-N7-guanine formation, and hepatic tumorigenesis in rats fed ethoxyquin: role of induction of glutathione S-transferases. Kensler TW; Egner PA; Davidson NE; Roebuck BD; Pikul A; Groopman JD Cancer Res; 1986 Aug; 46(8):3924-31. PubMed ID: 2873884 [TBL] [Abstract][Full Text] [Related]
17. Impacts of chemicals on liver cancer risk. Wogan GN Semin Cancer Biol; 2000 Jun; 10(3):201-10. PubMed ID: 10936069 [TBL] [Abstract][Full Text] [Related]
18. Protection against aflatoxin B1-induced hepatocarcinogenesis in F344 rats by 5-(2-pyrazinyl)-4-methyl-1,2-dithiole-3-thione (oltipraz): predictive role for short-term molecular dosimetry. Roebuck BD; Liu YL; Rogers AE; Groopman JD; Kensler TW Cancer Res; 1991 Oct; 51(20):5501-6. PubMed ID: 1680553 [TBL] [Abstract][Full Text] [Related]
19. Temporal patterns of covalent DNA adducts in rat liver after single and multiple doses of aflatoxin B1. Croy RG; Wogan GN Cancer Res; 1981 Jan; 41(1):197-203. PubMed ID: 7448760 [TBL] [Abstract][Full Text] [Related]
20. Exposure biomarkers in chemoprevention studies of liver cancer. Wild CP; Turner PC IARC Sci Publ; 2001; 154():215-22. PubMed ID: 11220661 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]